News & Updates

Show Multimedia Only

Six-food elimination diet improves symptoms of eosinophilic esophagitis

12 Jan 2023

Dietary elimination with specific food trigger identification may be used in place of medical therapy for the treatment of adults with eosinophilic esophagitis (EoE), an immune-mediated inflammatory condition with tissue eosinophilia resulting in esophageal dysfunction, suggests a study.

12 Jan 2023

Recent hyperglycaemia helps detect pancreatic cancer early

11 Jan 2023

Pancreatic cancer may be identified early if assessment will be steered towards the point of recent hyperglycaemia based on elevated HbA1c, suggests a retrospective cohort study, noting that such early detection may then improve survival in cancer patients.

11 Jan 2023

Meta-analysis: No link between PPI use and gastric cancer

11 Jan 2023

Proton pump inhibitor (PPI) therapy does not appear to put individuals who require gastric acid suppression at increased risk of gastric cancer, according to a study.

11 Jan 2023

Cirrhosis inpatients take more opioids, fewer nonopioid analgesics than noncirrhosis patients

10 Jan 2023

Inpatients normally use analgesics for pain, with comparable rates between those with and without cirrhosis, according to a recent study. Patients with cirrhosis, especially decompensated ones, are less likely to use acetaminophen and nonsteroidal anti-inflammatory drugs (NSAIDs) and more likely to use opioid analgesics.

10 Jan 2023

Supratherapeutic infliximab levels do not predict complications risk in CD patients

10 Jan 2023

Trough levels of infliximab are not predictive of the risk of short-term infectious (IC) or noninfectious complications (NIC) in adult patients with Crohn’s disease (CD), reports a study.

10 Jan 2023

$Refractory Crohn’s disease responds well to risankizumab$

Refractory Crohn’s disease responds well to risankizumab

09 Jan 2023

In the treatment of patients with luminal Crohn’s disease and multiple prior drug failures, risankizumab induces clinical response in about three out of four patients and steroid-free clinical remission in about half, according to a study.

09 Jan 2023

Adagrasib shows antitumour activity in KRAS G12C-mutant colorectal cancer

07 Jan 2023

Adagrasib appears to have some effect against metastatic, KRAS G12C-mutated colorectal cancer when used in treatment-experienced patients either as oral monotherapy or in combination with cetuximab, according to the results of a phase I-II, open-label study.

07 Jan 2023

Weekly dupilumab shots work well in eosinophilic esophagitis

07 Jan 2023

Weekly treatment with subcutaneous dupilumab yields improvements in histologic outcomes and symptoms in patients with eosinophilic esophagitis, according to the results of a phase III study.

07 Jan 2023